This announcement is a separate document:
君实生物自愿披露关于特瑞普利单抗获得欧盟委员会批准上市的公告
Junshi Biotech voluntarily disclosed the announcement that treprilizumab was approved for marketing by the European Commission
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated